drugset / Trial / NCT00766857
Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if exenatide will improve global cardiac function in patients with type 2 diabetes mellitus and congestive heart failure, by favorable effects on cardiac metabolism leading to improvement of cardiac efficiency.
Timeline
- Start
- 2009-05
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 10 ug | — |
| Comparator | insulin glargine | Protein / enzyme biologic | 10 iu | — |